Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays

Blood

Volumn 99, Issue 1, 2002, Pages 282-289

  Husson, Hervé ^b   Carideo, Elizabeth G ^b   Neuberg, Donna ^b   Schultze, Joachim ^b   Munoz, Olivier ^b   Marks, Peter W ^b   Donovan, John W ^b   Chillemi, Antoinette C ^b   O'Connell, Peter ^b   Freedman, Arnold S ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL COMPARTMENTALIZATION; CELL INTERACTION; DNA MICROARRAY; FOLLICULAR LYMPHOMA; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETIC COMPLEMENTATION; GENETIC REGULATION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0036095723     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.1.282     Document Type: Article

References (72)

1. Distinctive chromosomal abnormalities in histology, subtypes of non-Hodgkin's lymphomas
2. bcl-2-immunoglobulin transgenic mice demonstrated extended B cell survival and follicular lymphoproliferation
3. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14:18)
4. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals
5. Translocation t(14;18) in healthy individuals: Preliminary study of its association with family history and agricultural exposure
6. Detection of the t(14:18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients
7. BCL-2 translocation frequency rises with age in humans
8. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma
9. Molecular portraits of human breast tumours
10. Detection of differentially expressed genes in lymphoma using cDNA arrays: Identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas
11. Molecular classification of cutaneous malignant melanoma by gene expression profiling
12. Gene expression profiling in human peripheral blood mononuclear cells using high-density filter-based cDNA microarrays
13. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
14. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array
15. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
16. Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array
17. Genomic analysis of metastasis reveals an essential role for RhoC
18. Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis
19. Unbalanced expression of Bcl-2 family proteins in follicular lymphoma: Contribution of CD40 signaling in promoting survival
20. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by light cycler technology
21. A novel method for real time quantitative RT-PCR
22. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid upregulation of B7-1 and B7-2
23. Expression of human B cell associated antigens on leukemias and lymphomas: A model of B cell differentiation
24. Nodular lymphoma: Evidence for origin from follicular B lymphocytes
25. Low grade lymphomas: Expression of developmentally regulated B cell antigens
26. Immumoglobulin heavy-chain consensus probes for realtime PCR quantification of residual disease in acute lymphoblastic leukemia
27. Involvement of bcl-2 gene in human follicular lymphoma
28. Elevated circulating levels of TNFα and its p55 receptor are associated with an adverse prognosis in lymphoma patients
29. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas
30. Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells
31. The normal and malignant germinal centre
32. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
33. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFβ
34. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase
35. TGF-beta 1 induces the cyclin dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells
36. Anti-IgM induces transforming growth factor-beta sensitivity in a human B-lymphoma cell line: Inhibition of growth is associated with a downregulation of mutant p53
37. Blockade of TGFb3 up-regulation of p27Kip1 and p21Cip1 by expression of RasN17 in epithelial cells
38. Myeloid-related protein MRP8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel tubulin-dependent pathway
39. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils
40. Lymphoid cell aggregates: A useful clue in the fine-needle aspiration diagnosis of follicular lymphoma
41. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation
42. Constitutive expression of the Id1 gene impairs mouse B cell development
43. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2
44. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
45. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP
46. Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma
47. Chromosomal rearrangement of the PAX-5 locus in lymphoplastmacytic lymphoma with t(9;14)(p13;q32)
48. Loss of p53 function through PAX-mediated transcriptional repression
49. Expression of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system
50. Expression of Id2 and Id3 mRNA in human lymphocytes
51. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins
52. Overexpression of the helix-loop-helix protein Id2 blocks T cell development at multiple stages
53. Follicular non-Hodgkin's lymphoma cell adhesion to normal and neoplastic germinal centers involves VLA-4 and VCAM-1
54. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms
55. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4
56. Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor
57. Interleukin-2 receptor γ chain: A functional component of the interleukin-4 receptor
58. Cytokine expression by germinal center cells
59. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease
60. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system
61. Turning off follicular dendritic cells
62. Sequential shifts in the three major glycosphingolipid are associated with B cell differentiation
63. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34 hematopoietic stem cells: Implication for ex vivo tumor purging and autologous stem cell transplantation
64. CDK inhibitors: Positive and negative regulators of G1-phase progression
65. Genomic organization, 5′ flanking enhancer region, and chromosomal assignment of the cell cycle gene, p55Cdc
66. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations
67. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: Non-random chromosomal abnormalities and histological correlations
68. MYC rearrangements in histologically progressed follicular lymphomas
69. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: Clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies
70. Cytogenetic evolution patterns in non-Hodgkin's lymphoma
71. High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma
72. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma